Newsroom
Link to: Client news
Client news
The latest news from Optimum clients
Follow a manual added link
Weekly round-up
Read Optimum’s round-up for the low-down on client and industry news
Link to: The Event Guide: Jefferies Global Healthcare Conference & London Life Sciences Week 2026
The Event Guide
Jefferies Global Healthcare Conference 2026 & Life Sciences Week, London – produced by Catalyst Advisors & Optimum in partnership with Jefferies.
Weekly wrap-up: Optimum’s 16th Annual Healthcare Investor Conference is almost upon us!
/in InsightsThis week’s hot topic: prime editing moves closer to patients
/in InsightsWeekly wrap-up: $100m Series B financing for a bivalent vaccine, to new clinical data from a cutting-edge antibody-drug conjugate…
/in InsightsWeekly round-up: From a vaccine protein manufacturing collaboration, to the appointment of an orthopaedic devices expert…
/in InsightsWeekly round-up: The appointment of a new CEO to Phase 1 data from a novel GLP-1 receptor agonist…
/in InsightsWeekly round-up: AMSilk joins World Economic Forum’s Global Innovators Community
/in InsightsWeekly round-up: Looking ahead to a busy autumn 2024
/in InsightsWeekly round-up: Countdown to our Annual Healthcare Investor Conference has begun!
/in InsightsThe ‘must-attend’ Healthcare conferences Autumn / Winter 2024
/in InsightsResolution Therapeutics: pioneering macrophage therapies for liver diseases
/in InsightsCheck out Optimum’s podcasts this summer
/in InsightsNovo Holdings invests £50m in UK-Listed Oxford Nanopore Technologies
/in InsightsWeekly wrap-up: Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump
/in InsightsAsceneuron secures $100m Series C financing to progress neurodegeneration research, Novo Holding leads round with participation from existing investor Sofinnova Partners
/in InsightsNovo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates
/in Insights